[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343804-105":59,"doc-detail-343804-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","differential-protein-coding-gene-expression-profile-in-patients-with-prostate-cancer","Differential Protein-Coding Gene Expression Profile in Patients with Prostate Cancer","","Prostate cancer remains the second most common malignancy in men, with large projected incidence by 2045. Differentially expressed genes can improve diagnosis, treatment selection, monitoring, and prognosis. This study systematically reviews validated differentially expressed mRNAs in adult prostate cancer patients, applying PRISMA, STRING, Cytoscape, and DrugBank to map protein–protein interactions and candidate drug targets. Results include 144 mRNAs across 75 articles, largely RT-qPCR validated, yielding 25 mRNAs with clinical diagnostic potential. Findings support precision oncology development.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/differential-protein-coding-gene-expression-profile-in-patients-with-prostate-cancer/343804/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/differential-protein-coding-gene-expression-profile-in-patients-with-prostate-cancer/343804.png","ImageObject",300,407,{"name":92,"@type":93},"Quinn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the document’s main research purpose?","Question",{"text":112,"@type":113},"To systematically review and analyze validated differentially expressed mRNAs in prostate cancer patients and propose a robust molecular profile for clinical diagnostics.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were the candidate mRNAs validated and analyzed?",{"text":117,"@type":113},"The review followed PRISMA guidelines to identify mRNAs with validated differential expression in adult patients, and the identified mRNAs were analyzed using STRING, Cytoscape, and DrugBank.",{"name":119,"@type":110,"acceptedAnswer":120},"What key results were reported in the study?",{"text":121,"@type":113},"Across 75 primary articles and 5003 participants, 144 mRNAs (p \u003C 0.05) were reported, predominantly validated by RT-qPCR, and at least 36 mRNAs were identified as targets for cancer-related drugs.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},343804,1790176768,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962075114765,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","biomedicines  \nArticle  \nDifferential Protein-Coding Gene Expression Profile in Patients with Prostate Cancer  \nLorena Albarracín-Navas 1,2,3, Maylin Almonte-Becerril 4, Enmanuel Guerrero 1,2,3,5,6, Josue Rivadeneira 1,2,7, Marcelino Telechea-Fernández 8, Elizabeth Guzmán 3, Fanny Calderón 6, María José Hernández-Leal 1,2,9,10, Tamara Otzen 1,2,11, Carlos Manterola 1,2,11,12, Galo Duque 13 and Ángela L. Riffo-Campos 1,2,11, *  \nCitation: Albarracín-Navas, L.; Almonte-Becerril, M.; Guerrero, E.; Rivadeneira, J.; Telechea-Fernández, M.; Guzmán, E.; Calderón, F.; Hernández-Leal, M.J.; Otzen, T.; Manterola, C.; et al. Differential Protein-Coding Gene Expression Profile in Patients with Prostate Cancer. Biomedicines 2024, 12, 2509 . [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)biomedicines12112509  \nAcademic Editor: Gvantsa Kharaishvili  \nReceived: 17 July 2024  \nRevised: 2 August 2024  \nAccepted: 13 August 2024  \nPublished: 1 November 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Universidad de La Frontera, Ph.D. Program in Medical Sciences, Temuco 4811230, Chile; [l.albarracin01@ufromail.cl](l.albarracin01@ufromail.cl) (L.A.-N.); [enmanuel.guerrero@ucuenca.edu.ec](enmanuel.guerrero@ucuenca.edu.ec) (E.G.); [j.rivadeneira01@ufromail.cl](j.rivadeneira01@ufromail.cl) (J.R.); [mhernandezl.1@unav.es](mhernandezl.1@unav.es) (M.J.H.-L.); [tamara.otzen@ufrontera.cl](tamara.otzen@ufrontera.cl) (T.O.); [carlos.manterola@ufrontera.cl](carlos.manterola@ufrontera.cl) (C.M.)  \n2 Universidad de La Frontera, Millennium Nucleus on Sociomedicine (SocioMed), Temuco 4811230, Chile  \n3 Comprehensive Medical Services (SERMEDIC), Cuenca 010111, Ecuador  \n4 Executive Direction of Research and Advanced Studies, Universidad de la Salud, Mexico City 01210, Mexico; maylin.almonteb@unisa.cdmx.gob.mx  \n5 Faculty of Medicine, Universidad de Cuenca, Cuenca 010201, Ecuador  \n6 SOLCA Cancer Institute, Cuenca 010111, Ecuador  \n7 Zero Biomedical Research, Quito 170103, Ecuador  \n8 Faculty of Chemistry, Complutense University of Madrid, 28040 Madrid, Spain; [marcetel@ucm.es](marcetel@ucm.es)  \n9 University of Navarra, School of Nursing, Department of Community, Maternity and Pediatric Nursing, 31006 Pamplona, Spain  \n10 IdiSNA, Navarra Institute for Health Research, 31008 Pamplona, Spain  \n11 Center for Cancer Prevention and Control (CECAN), Santiago 8380453, Chile  \n12 Universidad de La Frontera, Center for Morphological and Surgical Studies (CEMyQ), Temuco 4811230, Chile  \n13 Faculty of Medicine, Universidad del Azuay, Cuenca 010107, Ecuador; [galoduque@uazuay.edu.ec](galoduque@uazuay.edu.ec)  \n* Correspondence: [angela.riffo@ufrontera.cl](angela.riffo@ufrontera.cl)  \nAbstract: Background: Prostate cancer is the second most common neoplasm in men, with projections estimating over one million new cases by 2045 . Differentially expressed genes can significantly enhance the diagnosis, treatment, monitoring, and prognosis of this disease. Purpose: to systematically review and analyze validated differentially expressed mRNAs in prostate cancer patients to propose a robust molecular profile for clinical diagnostics. Methods: A systematic review was conducted following PRISMA guidelines, searching literature databases for mRNAs with validated differential expression in adult prostate cancer patients. Identified mRNAs were analyzed using STRING, Cytoscape, and DrugBank to explore protein–protein interactions and potential drug targets. Results: A total of 5003 participants from Europe, Asia, America, and Oceania were included, and 144 mRNAs (p \u003C 0.05) were reported across 75 primary articles, predominantly validated usin","cbCaiuUOnlVNlhq6","https://ap.wps.com/l/cbCaiuUOnlVNlhq6","pdf",1274984,14,"English","# Introduction\n## Abstract\n## Methods\n## Results\n## Discussion\n# Conclusion","[{\"question\":\"What is the document’s main research purpose?\",\"answer\":\"To systematically review and analyze validated differentially expressed mRNAs in prostate cancer patients and propose a robust molecular profile for clinical diagnostics.\"},{\"question\":\"How were the candidate mRNAs validated and analyzed?\",\"answer\":\"The review followed PRISMA guidelines to identify mRNAs with validated differential expression in adult patients, and the identified mRNAs were analyzed using STRING, Cytoscape, and DrugBank.\"},{\"question\":\"What key results were reported in the study?\",\"answer\":\"Across 75 primary articles and 5003 participants, 144 mRNAs (p \\u003c 0.05) were reported, predominantly validated by RT-qPCR, and at least 36 mRNAs were identified as targets for cancer-related drugs.\"}]","Differential Protein-Coding Gene Expression Profile in Patients with Prostate Cancer | PDF",1790052183,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6f783e1e8fcd04a8729bf150dcecb86b.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/97959506e555d88a11882d9b1ee3d68d.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3900a904394da84b1bf883fd7d9a6cf4.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0b29938ef078e94af14870551a95e176.webp",980,1385]